Medicare Enrolled

Dr. Andrew Mak, M.D.

Hematology & Oncology · Amarillo, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1751 WALLACE BLVD, Amarillo, TX 79106
8062124673
In practice since 2015 (10 years)
NPI: 1306227376 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mak

Dr. Andrew Mak is a hematology & oncology in Amarillo, TX, with 10 years in practice. Based on federal Medicare data, Dr. Mak performed 388 Medicare services across 208 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mak received a total of $4,356 from 40 pharmaceutical and/or device companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mak is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ 388 Medicare services$ $4,356 industry payments

Medicare Practice Summary

Medicare Utilization ↗
388
Medicare services
Bottom 26% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
208
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)148$69$230
Office visit, established patient, complex (40-54 min)148$102$310
New patient office visit (45-59 min)55$90$350
Initial hospital admission, moderate complexity22$97$305
New patient office visit, complex (60-74 min)15$126$445
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,356
Total received (2020-2024)
Avg $871/year across 5 years
Top 46% in TX for hematology & oncology
40
Companies
105
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,865 (88.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$491 (11.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$953
2023
$1,282
2022
$855
2021
$776
2020
$489

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Incyte Corporation
$1,007
AstraZeneca Pharmaceuticals LP
$386
Astellas Pharma US Inc
$243
Janssen Biotech, Inc.
$235
Myriad Genetic Laboratories, Inc.
$218
Daiichi Sankyo Inc.
$198
Amgen Inc.
$178
Celgene Corporation
$170
Novartis Pharmaceuticals Corporation
$164
Kite Pharma, Inc.
$136
Eisai Inc.
$120
E.R. Squibb & Sons, L.L.C.
$119
Janssen Scientific Affairs, LLC
$106
EISAI INC.
$104
Genmab U.S., Inc.
$101
Merck Sharp & Dohme LLC
$82
Blueprint Medicines Corporation
$71
Takeda Pharmaceuticals U.S.A., Inc.
$66
PFIZER INC.
$65
Gilead Sciences, Inc.
$62
Genentech USA, Inc.
$58
ABBVIE INC.
$52
Alexion Pharmaceuticals, Inc.
$46
BeiGene USA, Inc.
$38
TerSera Therapeutics LLC
$34
ARRAY BIOPHARMA INC
$31
Dendreon Pharmaceuticals LLC
$28
Agios Pharmaceuticals, Inc.
$23
Acrotech Biopharma LLC
$23
SERVIER PHARMACEUTICALS LLC
$21
Seagen Inc.
$20
MorphoSys, US Inc.
$20
Lilly USA, LLC
$18
SpringWorks Therapeutics, Inc.
$18
Bayer Healthcare Pharmaceuticals Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Aveo Pharmaceuticals, Inc.
$17
CTI BioPharma Corp.
$15
Rigel Pharmaceuticals, Inc.
$14
ADC Therapeutics America, Inc.
$14
Top 3 companies account for 37.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Alecensa · BELEODAQ · BOSULIF · BRUKINSA · CALQUENCE · Columvi · DARZALEX · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Enhertu · FOTIVDA · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · PEMAZYRE · PIQRAY · PLUVICTO · PRECISETUMOR · PROMACTA · PROVENGE · PYRUKYND · Padcev · REBLOZYL · RYBREVANT · Stivarga · TAGRISSO · TASIGNA · TIVDAK · Tavalisse · Tivdak · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Vanflyta · Venclexta · Vonjo · Vyloy · XALKORI · Yescarta · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,123 per 100 Medicare services performed
Looking for a hematology & oncology in Amarillo?
Compare hematology & oncologys in the Amarillo area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
10
Per 100K population
8.6
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mak is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mak experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mak performed 148 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mak receive payments from pharmaceutical companies?
Yes. Dr. Mak received a total of $4,356 from 40 companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mak's costs compare to other hematology & oncologys in Amarillo?
Dr. Mak's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →